XML 76 R25.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment Reporting
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Segment Reporting   SEGMENT REPORTING

We operate primarily through three business segments: diagnostic and information technology-based products and services for the veterinary market, which we refer to as CAG; water quality products (“Water”); and diagnostic products and services for livestock and poultry health and to ensure the quality and safety of milk and improve producer efficiency, which we refer to as LPD. Our Other operating segment combines and presents products for the human point-of-care medical diagnostics market with our out-licensing arrangements because they do not meet the quantitative or qualitative thresholds for reportable segments. 

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (the "CODM"), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include: CAG, Water, LPD, and Other. Assets are not allocated to segments for internal reporting purposes.

CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. Water develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. LPD develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. OPTI Medical manufactures and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market.

Intersegment revenues, which are not included in the table below, were not material for the years ended December 31, 2019, 2018 and 2017.

Certain costs are not allocated to our operating segments and are instead reported under the caption “Unallocated Amounts”. These costs include costs that do not align with one of our existing operating segments which primarily consist of our R&D function, regional and country expenses, certain foreign currency revaluation and settlement gains and losses on monetary balances in currencies other than our subsidiaries’ functional currency and unusual items. Corporate support function costs (such as information technology, facilities, human resources, finance and legal), health benefits and incentive compensation are charged to our business segments at pre-determined budgeted amounts or rates. Differences from these pre-determined budgeted amounts or rates are also captured within Unallocated Amounts.


The following is a summary of segment performance:
(in thousands)
 
For the Years Ended December 31,
 
 
CAG
 
Water
 
LPD
 
Other
 
Unallocated Amounts
 
Consolidated Total
2019
 
 

 
 

 
 

 
 

 
 

 
 

Revenue
 
$
2,119,183

 
$
132,850

 
$
132,635

 
$
22,240

 
$

 
$
2,406,908


 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from operations
 
$
491,602

 
$
62,435

 
$
25,374

 
$
4,940

 
$
(31,505
)
 
$
552,846

Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
(30,628
)
Income before provision for income taxes
 
 
 
 
 
 
 
 
 
 
 
522,218

Provision for income taxes
 
 
 
 
 
 
 
 
 
 
 
94,426

Net income
 
 
 
 
 
 
 
 
 
 
 
427,792

Less: Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
 
 
72

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
 
 
 
 
 
 
 
 
 
 
$
427,720

 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
$
77,620

 
$
2,794

 
$
4,007

 
$
3,590

 
$

 
$
88,011


 
 
 
 
 
 
 
 
 
 
 
 
2018
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
1,935,428

 
$
125,198

 
$
130,581

 
$
22,035

 
$

 
$
2,213,242


 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from operations
 
$
429,483

 
$
56,607

 
$
19,412

 
$
3,729

 
$
(17,896
)
 
$
491,335

Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
(33,593
)
Income before provision for income taxes
 
 
 
 
 
 
 
 
 
 
 
457,742

Provision for income taxes
 
 
 
 
 
 
 
 
 
 
 
80,695

Net income
 
 
 
 
 
 
 
 
 
 
 
377,047

Less: Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
 
 
16

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
 
 
 
 
 
 
 
 
 
 
$
377,031

 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
$
72,789

 
$
2,592

 
$
4,094

 
$
3,703

 
$

 
$
83,178


 
 
 
 
 
 
 
 
 
 
 
 
2017
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
1,703,377

 
$
114,395

 
$
128,481

 
$
22,805

 
$

 
$
1,969,058

 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from operations
 
$
363,557

 
$
50,616

 
$
16,464

 
$
4,837

 
$
(22,446
)
 
$
413,028

Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
(31,971
)
Income before provision for income taxes
 
 
 
 
 
 
 
 
 
 
 
381,057

Provision for income taxes
 
 
 
 
 
 
 
 
 
 
 
117,788

Net income
 
 
 
 
 
 
 
 
 
 
 
263,269

Less: Net income attributable to noncontrolling interest
 
 
 
 
 
 
 
 
 
 
 
125

Net income attributable to IDEXX Laboratories, Inc. stockholders
 
 
 
 
 
 
 
 
 
 
 
$
263,144

 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
$
71,835

 
$
2,856

 
$
5,052

 
$
3,397

 
$

 
$
83,140



    
See "Note 3. Revenue Recognition" for a summary of disaggregated revenue by reportable segment and by major product and service category for the years ended December 31, 2019, 2018 and 2017.    

Net long-lived assets, consisting of net property and equipment, are subject to geographic risks because they are generally difficult to move and to effectively utilize in another geographic area in a reasonable time period and because they are relatively illiquid. Net long-lived assets by principal geographic areas were as follows:
(in thousands)
 
 
 
 
 
 
December 31, 2019
 
December 31, 2018
Americas
 
 
 
 
United States
 
$
401,248

 
$
348,240

Brazil
 
22,274

 
16,735

Canada
 
7,784

 
1,859


 
431,306

 
366,834

Europe, the Middle East and Africa
 
 
 
 
Germany
 
52,032

 
25,036

United Kingdom
 
12,114

 
11,517

Netherlands
 
13,586

 
10,273

France
 
2,061

 
2,130

Switzerland
 
3,508

 
2,742

Other
 
3,395

 
3,763


 
86,696

 
55,461

Asia Pacific Region
 
 
 
 
Japan
 
5,409

 
5,296

Australia
 
4,088

 
4,257

Other
 
6,346

 
5,422


 
15,843

 
14,975

Total
 
$
533,845

 
$
437,270